LeMaitre Vascular (LMAT) director receives dividend equivalent rights awards

Q: What did LeMaitre Vascular (LMAT) insider Joseph Pellegrino report on this Form 4?

He reported multiple grants of Dividend Equivalent Rights on June 4, 2026. These rights accrued on existing restricted stock unit and performance share unit awards and are compensation-related, not open-market stock purchases or sales.

Q: Are the LeMaitre Vascular (LMAT) Form 4 transactions open-market buys or sells?

No, the Form 4 shows award acquisitions coded as “A,” not open-market trades. The dividend equivalent rights accrue automatically on prior equity awards when dividends are paid, rather than reflecting discretionary buying or selling of common stock.

Q: What are Dividend Equivalent Rights in the LeMaitre Vascular (LMAT) filing?

Dividend Equivalent Rights are derivative rights that mirror dividends on common stock. In this filing, each right is the economic equivalent of one share of common stock and vests on the same schedule as the related restricted stock or performance share units.

Q: Which prior awards generated the Dividend Equivalent Rights for LMAT’s Joseph Pellegrino?

The rights accrued on restricted stock unit and performance share unit awards granted on 12/12/2022, 12/8/2023, 12/6/2024, and 12/10/2025. Each group of rights vests proportionately with its underlying award according to the original grant terms.

Q: Does this LeMaitre Vascular (LMAT) Form 4 change Joseph Pellegrino’s common stock holdings directly?

The filing reports derivative positions in dividend equivalent rights, not direct common stock trades. Each right is economically equivalent to one share and is linked to equity awards; it does not represent immediate cash transactions in the market.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

LeMaitre Vascular director Joseph P. Pellegrino Jr. reported several compensation-related grants of Dividend Equivalent Rights tied to existing equity awards. On June 4, 2026, he acquired small fractional rights on multiple restricted stock unit and performance share unit awards from prior grant dates.

Each dividend equivalent right is the economic equivalent of one share of LeMaitre Vascular common stock and vests proportionately with the underlying award. The transactions are coded as awards (not open‑market trades), so they reflect routine accrual of additional rights rather than buying or selling shares in the market.

Insider Trade Summary

7 transactions reported

Mixed 7 txns

Insider Pellegrino Joseph P JR

Role null

Type	Security	Shares	Price	Value
Grant/Award	Dividend Equivalent Rights	1.824	$0.00	--
Grant/Award	Dividend Equivalent Rights	1.824	$0.00	--
Grant/Award	Dividend Equivalent Rights	3.117	$0.00	--
Grant/Award	Dividend Equivalent Rights	3.734	$0.00	--
Grant/Award	Dividend Equivalent Rights	3.384	$0.00	--
Grant/Award	Dividend Equivalent Rights	3.834	$0.00	--
Grant/Award	Dividend Equivalent Rights	1.427	$0.00	--

Holdings After Transaction: Dividend Equivalent Rights — 23.342 shares (Direct, null)

Footnotes (1)

These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Key Figures

Dividend equivalent rights granted: 1.4274 rights Rights after first 2022 award accrual: 2.6351 rights Dividend equivalent rights granted: 3.8341 rights +2 more

5 metrics

Dividend equivalent rights granted 1.4274 rights Grant on June 4, 2026 tied to 12/12/2022 award

Rights after first 2022 award accrual 2.6351 rights Total dividend equivalent rights following that transaction

Dividend equivalent rights granted 3.8341 rights Grant on June 4, 2026 tied to 12/12/2022 performance award

Rights after major 2024 award accrual 28.0291 rights Total dividend equivalent rights following one 2024-related transaction

Award transactions recorded 7 acquisitions All coded as A (grant, award, or other acquisition)

Key Terms

Dividend Equivalent Rights, restricted stock unit award, performance share unit award, economic equivalent

4 terms

Dividend Equivalent Rights financial

"These dividend equivalent rights accrued on a restricted stock unit award"

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

restricted stock unit award financial

"These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022"

A restricted stock unit award is a promise by a company to give an employee a specified number of company shares at a future date if certain conditions are met, such as staying with the company or hitting performance goals. For investors, these awards matter because they can increase the total number of shares outstanding when converted, diluting existing holders, and they align employees’ incentives with shareholders’ interests much like giving a rising bonus that becomes real only after conditions are satisfied.

economic equivalent financial

"Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock."

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

06/05/2026 - 05:34 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pellegrino Joseph P JR

(Last)

(First)

(Middle)

C/O LEMAITRE VASCULAR, INC.

63 SECOND AVENUE

(Street)

BURLINGTON

MASSACHUSETTS

01803

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LEMAITRE VASCULAR INC [ LMAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Dividend Equivalent Rights	⁽¹⁾	06/04/2026		A		1.8244		⁽¹⁾	⁽¹⁾	Common Stock	1.8244	$0	23.342	D
Dividend Equivalent Rights	⁽²⁾	06/04/2026		A		1.8244		⁽²⁾	⁽²⁾	Common Stock	1.8244	$0	22.659	D
Dividend Equivalent Rights	⁽³⁾	06/04/2026		A		3.1166		⁽³⁾	⁽³⁾	Common Stock	3.1166	$0	26.7078	D
Dividend Equivalent Rights	⁽⁴⁾	06/04/2026		A		3.7342		⁽⁴⁾	⁽⁴⁾	Common Stock	3.7342	$0	28.0291	D
Dividend Equivalent Rights	⁽⁵⁾	06/04/2026		A		3.3843		⁽⁵⁾	⁽⁵⁾	Common Stock	3.3843	$0	18.7303	D
Dividend Equivalent Rights	⁽⁶⁾	06/04/2026		A		3.8341		⁽⁶⁾	⁽⁶⁾	Common Stock	3.8341	$0	18.5607	D
Dividend Equivalent Rights	⁽⁷⁾	06/04/2026		A		1.4274		⁽⁷⁾	⁽⁷⁾	Common Stock	1.4274	$0	2.6351	D

Explanation of Responses:

1. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

2. These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

3. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

4. These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

5. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

6. These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

7. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

	/s/ Laurie A. Churchill, Attorney-in-fact	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did LeMaitre Vascular (LMAT) insider Joseph Pellegrino report on this Form 4?

He reported multiple grants of Dividend Equivalent Rights on June 4, 2026. These rights accrued on existing restricted stock unit and performance share unit awards and are compensation-related, not open-market stock purchases or sales.

Are the LeMaitre Vascular (LMAT) Form 4 transactions open-market buys or sells?

No, the Form 4 shows award acquisitions coded as “A,” not open-market trades. The dividend equivalent rights accrue automatically on prior equity awards when dividends are paid, rather than reflecting discretionary buying or selling of common stock.

What are Dividend Equivalent Rights in the LeMaitre Vascular (LMAT) filing?

Dividend Equivalent Rights are derivative rights that mirror dividends on common stock. In this filing, each right is the economic equivalent of one share of common stock and vests on the same schedule as the related restricted stock or performance share units.

Which prior awards generated the Dividend Equivalent Rights for LMAT’s Joseph Pellegrino?

The rights accrued on restricted stock unit and performance share unit awards granted on 12/12/2022, 12/8/2023, 12/6/2024, and 12/10/2025. Each group of rights vests proportionately with its underlying award according to the original grant terms.

Does this LeMaitre Vascular (LMAT) Form 4 change Joseph Pellegrino’s common stock holdings directly?

The filing reports derivative positions in dividend equivalent rights, not direct common stock trades. Each right is economically equivalent to one share and is linked to equity awards; it does not represent immediate cash transactions in the market.